• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Chemours Company

    5/29/25 4:35:48 PM ET
    $CC
    Major Chemicals
    Industrials
    Get the next $CC alert in real time by email
    SD 1 cc-fy25_conflict_mineral.htm SD SD

     

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM SD

    Specialized Disclosure Report

     

    The Chemours Company
    (Exact Name of Registrant as Specified in Its Charter)

     

     

     

     

     

     

     

    Delaware

     

    001-36794

     

    46-4845564

    (State or Other Jurisdiction

     

    (Commission

     

    (I.R.S. Employer

    Of Incorporation)

     

    File Number)

     

    Identification No.)

     

    1007 Market Street

    Wilmington, Delaware 19801

    (Address of principal executive offices)

     

    Kristine Wellman, Senior Vice President, General Counsel and Corporate Secretary, (302) 773-1000
    (name and telephone number, including area code, of the person to contact in connection with this report.)

     

     

     

    Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

     

     Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.

     

     

     

     

     

     

     

     

     


     

    Section 1 — Conflict Minerals Disclosure

     

    Item 1.01 Conflict Minerals Disclosure and Report

     

    The Chemours Company (“Chemours”) conducted, in good faith, a reasonable country of origin inquiry regarding conflict minerals necessary to the functionality or production of its products that were manufactured, or contracted to be manufactured, by Chemours and for which the manufacture was completed during calendar year 2024.

    Based on Chemours’ reasonable country of origin inquiry, the Company exercised due diligence on the source and chain of supply of conflict minerals for 2024 manufactured products and thus has filed a Conflict Minerals Report.

     

    Conflict Minerals Disclosure

     

    A copy of Chemours’ Conflict Minerals Report is provided as Exhibit 1.01 to this Form SD and is publicly available in the Investor Relations section of the Company’s website under the header “Financials: SEC Filings” at www.chemours.com. The content of the website referenced is included for information only and is not incorporated by reference into this Form SD.

     

    Item 1.02 Exhibit

     

    The Company is filing its Conflict Minerals Report as Exhibit 1.01 to this report.

     

    Section 2 — Resource Extraction Issuer Disclosure

     

    Item 2.01 Resource Extraction Issuer Disclosure and Report

     

    Not applicable.

     

    Section 3 — Exhibits

     

    Item 3.01 Exhibits

     

    Exhibit 1.01 Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD.

     

     

     

     


     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

     

     

     

    THE CHEMOURS COMPANY

    (Registrant)

     

    /s/ Shane Hostetter

    Shane Hostetter

    Senior Vice President, Chief Financial Officer

    May 29, 2025

     

     

     


    Get the next $CC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CC

    DatePrice TargetRatingAnalyst
    3/27/2025$19.00Neutral → Outperform
    Mizuho
    1/28/2025$27.00Buy
    Truist
    7/9/2024$28.00 → $30.00Neutral → Buy
    UBS
    6/7/2024$25.00Neutral
    Mizuho
    4/9/2024$19.00 → $34.00Underperform → Outperform
    BMO Capital Markets
    3/5/2024$37.00 → $21.00Buy → Neutral
    UBS
    2/29/2024$45.00 → $19.00Outperform → Underperform
    BMO Capital Markets
    12/1/2023$28.00 → $40.00Sector Perform → Outperform
    RBC Capital Mkts
    More analyst ratings

    $CC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Gumpel Damian bought $201,376 worth of shares (21,222 units at $9.49), increasing direct ownership by 19% to 131,701 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      6/4/25 8:32:18 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chief Financial Officer Hostetter Shane bought $50,196 worth of shares (4,450 units at $11.28), increasing direct ownership by 8% to 59,694 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      5/21/25 5:13:57 PM ET
      $CC
      Major Chemicals
      Industrials
    • Director Cowan Alister was granted 14,096 shares, increasing direct ownership by 65% to 35,831 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      4/24/25 5:36:51 PM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • The Chemours Company Provides Update on Second Quarter 2025 Outlook

      The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today provided an update on its second quarter 2025 outlook. For the second quarter of 2025, due to better-than-expected performance, TSS now anticipates a sequential increase in Net Sales of approximately 25% driven by strong demand for Opteon™ Refrigerants, in connection with the stationary transition to low global warming potential refrigerants under the U.S. AIM Act. Consistent with this increased demand, TSS also projects a sequential increase in Adjusted EBITDA of nearly 40%

      6/18/25 6:45:00 AM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Appoints Matthew Conti as Chief Human Resources Officer

      Seasoned HR executive supports Chemours' Pathway to Thrive strategy The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Matthew Conti as Chief Human Resources Officer (CHRO), effective June 2. His appointment follows an extensive external search to identify a leader who will drive Chemours' people and culture strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612880421/en/Chemours appoints Matthew Conti as Chief Human Resource

      6/12/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio

      The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company, announced the appointment of Nathan Blom as Vice President of its liquid cooling portfolio, effective June 9, 2025. With Blom's wealth of technology and data center experience, his addition reinforces Chemours' commitment to driving near- and long-term growth in the liquid cooling market. Bringing over two decades of experience in executive leadership, business transformation, and go-to-market strategy across the technology and data center infrastructure sectors, Blom is a strong addition to Chemours leadership. The appointment supports the company's "Pathway to Thrive" strategy, with liquid cooling representing a ke

      6/10/25 6:45:00 AM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by Chemours Company

      SCHEDULE 13G - Chemours Co (0001627223) (Subject)

      6/10/25 4:00:13 PM ET
      $CC
      Major Chemicals
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Chemours Company

      SCHEDULE 13G/A - Chemours Co (0001627223) (Subject)

      6/6/25 10:03:48 AM ET
      $CC
      Major Chemicals
      Industrials
    • SEC Form SD filed by Chemours Company

      SD - Chemours Co (0001627223) (Filer)

      5/29/25 4:35:48 PM ET
      $CC
      Major Chemicals
      Industrials